Environmental Health Sciences Research Center

University of Iowa College of Public Health

You are here: Home / About / EHSRC News

Dr. Field recognized as National Radon Hero

By

The Conference of Radiation Control Program Directors (CRCPD) has selected Bill Field, University of Iowa professor emeritus of occupational and environmental health and member of the EHSRC, to receive the organization’s 2022 Radon Hero Award. The award recognizes an individual who has demonstrated leadership in reducing the health effects of radon exposure, the second leading cause of lung cancer in the United States. The award is based on the recipient’s contributions to this effort, the breadth and scope of their services, and sustained commitment to mitigating radon risk.  He was previously awarded Honorary Membership to CRCPD in 2010.

Official presentation of the CRCPD Radon Hero Award will occur during the organization’s annual radon meeting in October 2022.

Field is recognized as one of the foremost authorities on radon, not only for his research into the radioactive gas, but because of his advocacy and outreach efforts. He helped identify radon as the leading environmental cause of cancer deaths in the United States, and remains dedicated to educating the public about the health risks of radon and ways to reduce exposure in homes, schools and at work.

 

This post was originally posted on the UI College of Public Health website. 

N95s, KN95s best mask for protecting against COVID-19 on campus, experts say

By

This story was published in the Daily Iowan on February 6, 2022 by Kate Perez and features EHSRC Member Dr. Patrick O’Shuaghnessy, who is the Director of the Exposure Science Facility.
University of Iowa health experts say that the best mask to wear to protect yourself is an N95 mask. The recently distributed KN95s provide the second-best protection, and the worst are the blue surgical masks, according to Center for Disease Control and Prevention guidance.

University of Iowa health experts recommend the UI community to wear KN95 masks instead of surgical masks to offer better protection against COVID-19.

Patrick O’Shaughnessy, director of graduate studies in the UI College of Public Health Department of Occupational and Environmental Health, said N95 masks are most effective because of the tight seal formed to the face while wearing them, while the surgical masks are least effective.

“[N95 masks are] definitely the best protection. The surgical masks they’ve been passing out give the least protection,” he said. “They were designed for source control. They’re designed to protect others from you. They’re designed to catch your output from your mouth, the droplets coming out as you talk, to prevent the transmission that way.”

When the masks are looser, like the surgical ones, O’Shaughnessy said more leakage occurs out of the mask’s sides.

O’Shaughnessy said it is better to wear a KN95 mask from the university than a surgical one, as surgical masks are not supposed to be used as the main way of combating COVID-19.

“They were never designed to be a complete protection for the person wearing them,” O’Shaughnessy said. “That’s where it’s really important for the whole campus community together to be wearing the [KN95] masks.”

The UI announced on Jan. 12 that it would stock each university building health station with KN95 masks, an upgrade from the blue surgical masks given out during the first semester.

O’Shaughnessy said he ranks the KN95 masks that the UI are giving out somewhere in the middle of the other two types of masks, as they can form a tighter seal to the mouth than the surgical masks.

“Especially with the nose metal piece there, you get a better seal around your nose with the KN95,” O’Shaughnessy said. “They filter very similarly to the N95s. It really just comes down to the construction of the mask and how well it fits against your face.”

In an email to The Daily Iowan, Jeneane Beck, assistant vice president for external relations, wrote that the UI follows the Centers for Disease Control and Prevention guidelines when evaluating masks.

Lately, counterfeit masks have been spreading throughout the country, with the CDC reporting that about 60 percent of KN95 respirators the National Institute for Occupational Safety and Health evaluated during the pandemic in 2020 and 2021 did not meet their requirements.

Deborah Zumbach, associate vice president and director of parking and transportation and business services at the UI, wrote in a statement to the DI that the university requests authenticity documentation before making purchases, including the distributed masks.

“The university is fortunate to have an experienced team making regular purchases for a large academic medical center,” Zumbach wrote. “This results in business relationships with a variety of reliable vendors and suppliers in the United States. When making any purchase, the team requests all available documentation regarding a product’s efficacy and authenticity.”

The KN95 masks that are being distributed are from the company Dayhelp. The Dayhelp website states that the masks are FDA Registered Class 1. However, the company is not listed on the CDC website as a NIOSH-approved manufacturer of N95 respirators.

According to the CDC, surgical masks are loose-fitting, disposable, and create a physical barrier between the nose and the mouth of the wearer. These masks, however, may not provide as much protection compared to a KN95 mask.

“While a surgical mask may be effective in blocking splashes and large-particle droplets, it does not filter or block very small particles in the air that may be transmitted by coughs, sneezes, or certain medical procedures,” the CDC website states. “Surgical masks also do not provide complete protection from germs and other contaminants because of the loose fit.”

Dan Diekema, professor of internal medicine and associate hospital epidemiologist, said in a recent post on the UI Hospitals and Clinics’ website that he recommends people wear a medical-grade mask, whether it is a surgical, KN95, or N95 mask.

“We also consider unfitted N95s and KN95s to be equivalent to a medical-grade mask because they fit snugly against the face, allowing for fewer particles to break through,” Diekema said. “The most important thing is the fit to the face to protect the person wearing the mask, as well as others.”

Lehmler Receives 2021 John Doull Award

By

EHSRC Director Dr. Hans-Joachim Lehmler was presented the 2021 John Doull Award at the annual Central States Society of Toxicology (CSSOT) Meeting, held virtually this year.  As part of the award ceremony, Dr. Lehmler delivered a presentation titled, “PCB metabolism and neurotoxicity: highlights from a transatlantic journey.”

The John Doull award is presented each year by the CSSOT to honor the contributions of its members to the discipline of toxicology and the chapter.  Each year there is a call for nominations prior to the Fall meeting. The winner of the award receives a medal.

Lehmler joined the University of Iowa in 2003 and currently leads a productive chemical toxicology laboratory linking the metabolism of current and emerging environmental contaminants, such as polychlorinated biphenyls (PCBs), pesticides, and environmental bisphenols, to their adverse health effects. He is internationally recognized for his studies on the disposition and toxicity of chiral PCBs. His current NIEHS-funded research employs novel animal models, including germ-free mice, transgenic animals, and population-based animal models, to characterize how the metabolism of chemical hazards affects toxic outcomes.

Dr. Lehmler serves as the Director of the NIEHS-funded Environmental Health Sciences Research Center (EHSRC) at the University of Iowa. In addition to his role as EHSRC Director, Dr. Lehmler is among the leadership team of the Exposure Science Facility and serves as the director of the Career Development Program of the EHSRC.

He also is the Deputy Director of the Iowa Superfund Research Program. Under this program, Dr. Lehmler leads a new Research Project investigating the neurotoxicity of polychlorinated biphenyls (PCBs) in adolescence. This Research Project brings together a multidisciplinary research team to study how local PCB metabolism in the brain affects neurotoxic outcomes in an adolescent rat model. Dr. Lehmler also leads the Synthesis Core of the Iowa Superfund Research Program and is a member of the leadership team of the Analytical Core.

He serves as Academic Editor of PLOSone and on NIH and DoD grant review panels. In addition, he is actively involved in the Central States Chapter of the Society of Toxicology and previously served as the Chapter’s secretary/treasurer for six years.

Dr. Mangalam’s work featured as a NIEHS Paper of the Month

By

A recent publication by EHSRC member Dr. Ashutosh Mangalam’s group was featured as an E-Factor Paper of the Month NIEHS Environmental Factor Newsletter as a Paper of the Month! The E-Factor Papers of the Month highlight the highest impact and most innovative research funded by NIEHS. Congratulations to the authors!

Citation: Jensen SN, Cady NM, Shahi SK, Peterson SR, Gupta A, Gibson-Corley KN, Mangalam AK. 2021. Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis. Sci Adv 7(28):eabd4595.

As written in Environmental Factor Newsletter:

Combination of a plant-based diet and specific gut microbes may protect against multiple sclerosis

A new NIEHS-funded study in mice showed that a diet rich in the plant-based compound isoflavone may protect against multiple sclerosis (MS). The isoflavone diet was only protective when the mice had gut microbes capable of breaking down isoflavones. MS is a disease in which the immune system attacks nerves in the brain and spinal cord, resulting in muscle weakness and loss of balance or coordination.

The researchers fed mice with MS characteristics an isoflavone-rich or isoflavone-free diet for six weeks. They measured levels of inflammatory cells in the brain and spinal cord, a hallmark of MS, and characterized the makeup of the gut microbiome.

Mice fed an isoflavone-free diet had more severe disease, with greater numbers of inflammatory cells in the brain and spinal cord, than mice fed isoflavone-rich diets. Isoflavone-free mice lacked isoflavone-metabolizing gut bacteria, which were abundant in mice fed the plant-based compounds. When the researchers fed mice isoflavones but removed isoflavone-metabolizing bacteria, the diet no longer protected against MS-like symptoms. When the bacteria were restored, the protective effect of the isoflavone diet returned. Furthermore, the researchers showed that isoflavone-free mice given equol, a metabolite produced when gut bacteria breakdown isoflavone, were also protected against MS.

Results suggest that the development and severity of MS is influenced by both diet and the makeup of the gut microbiome. According to the authors, results can inform therapies for patients with MS.